Proven.
Over 30 pharmaceutical-standard clinical trials and studies prove FlexNow with 100% SheaFlex70 has a statistically significant and clinically meaningful impact on joint care and management. Our experience includes human, double-blind, placebo-controlled university hospital clinical trials. Studies you can trust, by professionals you can trust.
FlexNow® with 100% SheaFlex70™ is clinically proven to impact all four of the areas required to realize healthy joint function: inflammation, cartilage retention, bone maintenance, and pain. In particular, FlexNow with 100% SheaFlex70 has been proven to:
- Reduce inflammation by 9 times
- Improve cartilage retention by 44%
- Increase bone retention by 10%
- Alleviate pain by 45%
When compared with other joint care interventions, whether pharmaceutical, OTC or natural, FlexNow with 100% SheaFlex70 has been clinically proven to result in more relief and better function.
- Glucosamine/Chondoitin: 48% better than glucosamine/chondroitin; get even more relief when FlexNow® with 100% SheaFlex70™ is added to your GS/CS regimen. Glucosamine and chondroitin are joint building blocks, but only support 30% of the cartilage matrix (called proteoglycans); FlexNow® with 100% SheaFlex70™ impacts the other 70% of the cartilage matrix (called collagen)
Learn more about the
Learn more about - Pharmaceutical interventions: Clinical benefits are similar, particularly for inflammation, without the side effects
Learn more about
Learn more about - Over the counter options: Taken every day, pain management exceeds the benefits of common OTC products, without the side effects
Learn more about
To learn more, please review our
– there are over 30 to date, and more being developed every day.